Abbott Laboratories Stock - sector comparison after a muted week

Abbott Laboratories stock has had a relatively quiet trading week, leaving investors to measure its performance against other major healthcare names and the broader Standard & Poor's 500 index while watching for the next catalysts from management and regulators.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:40 UTC. Details in the imprint.

Abbott Laboratories (US0028241000) remains one of the larger names in US healthcare after a relatively muted week for the shares. With no fresh company-specific headlines from major wire services, the focus turns to how the stock stacks up against peers and the broader market.

How Abbott compares this week

Abbott is a long-standing member of the Standard & Poor's 500 index and sits squarely in the large-cap healthcare space alongside Johnson & Johnson, Medtronic and Thermo Fisher Scientific. Its diversified portfolio means investors often compare it with both device makers and diagnostics specialists.

While precise week-to-date percentage changes vary intraday, Abbott shares have traded without dramatic swings, in contrast to some smaller biotech names that saw double-digit moves on trial news. That muted pattern keeps the emphasis on fundamentals and relative valuation, rather than short-term headlines.

Peer group and sector backdrop

Within the healthcare sector, Abbott competes for investor attention with other dividend-paying blue chips that offer a mix of stability and moderate growth. Many of these names also operate in medical devices or diagnostics, providing similar exposure to hospital and lab spending trends.

Sector exchange-traded funds tracking US healthcare have generally moved less than the more cyclical parts of the market in recent months. For Abbott, that defensive profile can be a feature for investors who prioritize cash flows and balance sheet strength over rapid top-line expansion.

How the company makes money

Abbott Laboratories generates revenue from four main segments: medical devices, diagnostics, established pharmaceuticals and nutrition products for adults and children. Flagship lines include glucose monitoring systems, core lab diagnostics platforms and branded infant and adult nutrition formulas.

Where the stock trades today

The shares of Abbott Laboratories (US0028241000) trade on the New York Stock Exchange at approximately $85 per share as of 06/19/2026, 13:40 UTC.

Key facts on Abbott Laboratories stock

• Company: Abbott Laboratories Inc.
• ISIN: US0028241000
• WKN: 850103
• Ticker: ABT
• Venue: NYSE
• Price (as of 06/19/2026, 13:40 UTC): 85.00 USD
• Market cap: 150,000,000,000 USD (as of 06/19/2026)
• Sector / Industry: Health Care / Medical Devices & Diagnostics
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.